Introduction
Remedy for cancer is certainly one of the big medical challenges to the scientists of 21 st century and is one of the current research hotspots. The escalating research to fight against cancer is getting us closer to a future, where cancer becomes a curable disease. As a researcher, we dream of curing cancer as easy as the deadly diseases viz., chickenpox, smallpox, polio, measles, sars (severe acute respiratory syndrome), yellow fever, malaria etc., [1] . Although existing drugs show efficacy, their lack of selectivity for tumor cells over normal cells can lead to severe side effects [2] . Cancer is caused by mutations that transform healthy cells into tumor cells. Recent studies have demonstrated that there will not be a match between tumors of two patients. It implies that the scientists should work on medicines that are tailored to cure a specific patient.
Platinum based drugs are actively used in treating various types of cancers; however, drug resistance, adverse side effects and low specificity are common in platinum chemotherapy [3, 4] .
To overcome these abnormalities to great extent, in recent years other metal based drugs have been developed and tested for their anticancer efficacy [5] . Important ones are the coordination compounds of Ni(II), Cu(II), Zn(II) and Ru(II) which can overcome the limited activity of cisplatin and its analogous [6, 7] .
Our current research puts in effort to crack a new anticancer drug candidate which could prove to be a better medicine. In our present work, the hydrazone Schiff base ligands derived from 9-oxo-9H-fluorene-1-carboxylic acid and their respective Co(II), Cu(II) and Ni (II) complexes are synthesized impeccably and analyzed. Hydrazones play an important role in inorganic medicinal chemistry. They can easily form stable complexes with transition metal ions and can exhibit interesting photophysical and biological properties [8] . They exhibit biological activities such as antibacterial [9] , antioxidant [10] , antifungal [11] , antitubercular [12] , antiinflammatory [13] and anticancer [14] .
Fluorenone is no doubt a polycyclic aromatic compound, one could doubt about its therapeutic property. But the literature reveals that derivatives of fluorenone have exhibited interesting biological activities. Arylsulfonylspiro[fluorene-9,5΄-imidazolidine]-2΄,4΄-diones are found to be effective as aldose reductase inhibitors [15] . Azabenzo[a]fluorene-5,6-diones have comparable cytotoxicities against cancer cell lines in vitro, with that of standard drug doxorubicin [16] . Our previous publication [17] have successfully established the anticancer efficacy of copper complex of fluorenone based ligand; which exhibited better anticancer activity against human breast carcinoma (MCF-7) cell line when compared to that of standard drug paclitaxel.
These results prompted us to synthesize new ligands which are embedded with fluorenone moiety, carboxylic acid, carboxamide and hydrazone groups. The metal complexes are synthesized from these ligands via eco-friendly routes employing green solvents. The ligands
and respective metal complexes were tested for their anticancer activities with MTT assay against breast cancer (MCF-7) cell line, DNA cleavage study was performed using pBR322 plasmid DNA. Antioxidant activity study was carried out through DPPH free radical-scavenging ability assay. Molecular docking studies were also carried out to examine the bonding mode of synthesized compounds.
Experimental

Materials and Physical Methods
All the raw materials including reagents, catalysts, solvents and drying agents were of fine [21] .
Inhibition Percentage = OD of Test sample ÷ OD of control × 100
Statistical analysis
All experiments were performed in triplicates (n = 3) and the numerical data are presented as mean ± standard deviation (SD).
Photocleavage of pBR322 DNA
The DNA cleavage activity of the newly synthesized ligands and their metal complexes was monitored by Agarose gel electrophoresis on pBR322 DNA (200 ng) in TAE buffer (40 mM Tris-Acetate, 1 mM EDTA) to yield a total volume of 10 µL and then incubated in dark for 30 min at 37 °C. Different concentrations of compounds were tested; 10, 30, 50 and 100 µgmL -1 .
The reaction was incubated at 37 °C for 2 h and 3 µL of loading buffer (bromophenol blue in H 2 O) was added to each tube and the mixed samples were loaded on 1% Agarose gel. The electrophoresis was carried out for 2 h at 50 V in Tris-acetate-EDTA buffer (pH 8.3). After electrophoresis, the gel was stained with Ethidium bromide (EB) for 30 min prior to being photographed under UV light [22, 23] . The cleavage properties were determined based on the ability of compounds to convert the supercoiled form (Form I) into nicked form (Form II). The results were compared with standard DNA marker and control DNA.
Molecular Docking Studies
In the present anticancer docking study B-cell lymphoma-extra large (BCl-XL) protein (PDB ID: 3ZK6) was used as drug target in molecular docking studies to computationally prove the anticancer potentialities of newly synthesized metal complexes and ligands. The crystal structure of the BCL-XL protein bound to its respective inhibitor was collected from Protein Data Bank (PDB) database. The site to which the inhibitor molecule was bound was identified using PDBSum server. Optimization of target protein by removal ligands and hetero atoms was carried out using Discovery Studio tool. 3D coordinates files of newly synthesized compounds in ".pdb"
format were generated using marvin sketch tool. Further these files were converted from ".pdb"
to ".pdbqt" file format using Autodock 4 tool. Automated molecular docking was carried out to determine the best orientation of the newly synthesized compounds possessing anti-cancer property was hypothesized as inhibitors bound in the active site of BCL-XL protein. A Lamarckian genetic algorithm implemented in the Auto Dock 4.0 program was employed [24] .
The grid map was set by adjusting the grid box centered at the following active pocket residues of the BCL-XL protein
Ala104(B), Phe105(B), Gly138(B) and Tyr195(B)]. These active pocket residues were used to generate with the AutoGrid file. The Lamarckian genetic algorithm was applied for minimization, using default parameters. The number of docking runs was 10, the population in the genetic algorithm was 250, the number of energy evaluations was 100,000, and the maximum number of interactions was 10,000 [25] .
DPPH Free Radical-Scavenging Ability Assay
In the present study, radical scavenging activity of ligands and their respective metal complexes was evaluated using the DPPH (1,1-diphenyl-2-picrylhydrazyl) radical as a reagent [26] .
Required volume of a DPPH radical solution in ethanol (60 µM) was mixed with different concentrations of testing samples. The mixture was incubated for 30 min in dark at room temperature. After the incubation, the absorbance of the reaction mixture was measured at 517 nm using a UV-Vis Spectrophotometer. For the positive control ascorbic acid was used as a reference standard. The DPPH scavenging activity of each sample was calculated using the following equation:
Where, A c is the absorbance of the control reaction (100 µL of ethanol with 100 µL of the DPPH solution) and A t is the absorbance of the test sample. The experiment was done in triplicate. The IC 50 value was calculated for all the samples. Lower absorbance of the reaction mixture indicates higher free radical activity.
Results and Discussion
Spectral Characterization
IR Spectral Studies
To identify the bonding mode as well as the complexation behavior, the IR spectra were recorded as well, the spectrum shows weak broad band at 2523 cm -1 due to carboxylic acid ν(O-H)
vibrations. The ν(N-H) vibrations appeared at 3325 cm -1 . The sharp intense band at 1705 cm -1 is assigned to ν(C=O) of carboxylic acid group. The sharp band at 1680 cm -1 is due to hydrazone ν(C=N) group. In both the ligands the amide stretching is not clearly visible, which could be due to overlapping with the carboxylic acid group. The diagnostic IR frequencies of ligands and their respective metal complexes are compiled in Table 1 . for nickel and cobalt complexes as well. The mass spectral data is matching very well with the predicted molecular weights of the compounds and this confirms the formation of metal complexes in each case [33, 34] . The mass spectra of nickel and cobalt complexes are reproduced in spectrum 13 to 16 of supplementary material. 
Electronic Spectral Studies
Thermal Analysis Studies
Thermal behavior of all the metal complexes was studied over a temperature range of 25 
reproduced in entry 20 of supplementary material. The copper (II) complex is highly stable up to 290 °C. Later on from 300 -480 °C, the metal complex decomposes in only one significant step and 91% of weight loss is observed. It matches very well with the theoretical value of 92.1% for the loss of two ligand groups and it clearly infers that, only ligand moiety is present in the complex has lost. After 500 °C, the plateau is observed till the stable metal oxide formation takes place [38] . This result is in line with the IR, electronic spectral and GC-MS data. Similar plot is observed for Ni(II) and Co(II) complexes as well and the observed results are in line with the calculated weight losses. Thus, the thermal data of the metal complexes give no evidence for the presence of any other coordinated moieties like water, chloride etc.
Molar Conductance Studies
Molar conductance of all the metal complexes was measured at 25 °C by preparing mmol solutions in DMF using the conductivity bridge (G* = 1). The values obtained for the complexes not exceeded 20 Ω -1 cm 2 mol -1 which confirms the non-electrolytic nature of metal complexes [39] . The molar conductance values have been reproduced in Table 3 along with the elemental analyses data which are in well agreement with the calculated percentages of each element. The detailed experimental results of molar conductance study have been tabulated in Table 4 . 
Bioassay Results
Anticancer activity of ligands and their metal complexes against breast cancer cells (MCF-7)
In the present investigation, in vitro MTT cell viability model was taken to study the cytotoxic Table 5 and 6 respectively. Concentration dependent cell viability was observed in all treated samples, the cell viability decreased with increase in concentration. In case of all tested drugs, dose dependant activity was observed with salient features.
The IC 50 value of 2 and Ni(L 2 ) 2 compounds is found to be less than 10µgmL -1 and other tested drugs also demonstrated very promising activity (Table 7) . Compared with control group, the cells treated with ligands and metal complexes showed significant detach in culture medium. There was a decrease in number of cells as well as observable abnormalities in the treated group of cells such as turgidity, shrunken in shape, cell breakage, cell shrinkage and apoptotic bodies are observed compared to untreated control cells. Microscopic examination revealed that morphological changes and shrinkage of cells occurred, leading to cell apoptosis induced by tested compounds [40, 41] . IC 50 values of ligands and their respective metal complexes in µgmL -1 for the MCF-7 cell line are compiled in Table 5 . Table 5 Cell viability data of ligands L 1 H and its metal complexes for MCF-7 cell line at five different concentrations. 
MCF-7
Ni(L 2 ) 2 <10
DNA Cleavage Studies
Designing small molecules help in targeting specific sites on a DNA strand and can lead to novel therapeutic agents. Photocleavage study of DNA also helps in various applications like photodynamic therapy of cancers, DNA foot printing agents and in genomic research [42, 43] .
Interaction of metal complexes with pBR322 DNA was studied using breaks and smear appearance [44, 45] . Overall findings have revealed that the tested compounds can successfully cleave the DNA as it is evident from the images reproduced in Fig. 9 . 
Molecular Docking Studies
In case of cancer, some class of proteins makes the failure of apoptosis by inhibiting the action of Table 8 . 
DPPH Free Radical-Scavenging Ability
Free radicals lead to the severe causes and implications in the occurrence of various diseases such as liver cirrhosis, atherosclerosis, cancer, diabetes and aging [47] . Antioxidants play an important role in the control of free radicals by delaying or inhibiting its activity. Many previous reports show that Schiff bases are the selective molecules which can prevent the activity of free radicals and acts as potent antioxidants.
In the present study, percent inhibition values of DPPH of synthesized compounds were analyzed and compared with Vitamin C (Ascorbic acid) used as standard in different 
